Epervudine

This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3G05PH9FAS. European Medicines Agency schedules Epervudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06561MIG. Epervudine generally arises in the molecular formula C12H18N2O5. The term EPERVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) EPERVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule epervudine under HS 29349990 and SITC 51579. As of Q4 2014, EPERVUDINE remains the US FDA Preferred Term for this commodity. Epervudine bears US NLM identifiers UMLS ID C2700002 and NCI Concept Code C76916. SMILES: CC(C)C1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O.